when she was nine months old, lacoste-hofmann’s doctors inserted a blalock-thomas-taussig shunt, a temporary measure to increase blood flow to her lungs and decrease her risk of turning blue. (it’s actually called “the blue baby operation.”)
at around four, she began taking commonly used drugs prescribed to chd patients, such as digoxin, amiodarone, coumadin, beta-blockers, inotropes, and, when she got infections, antibiotics.
at 10, lacoste-hofmann’s health took a downturn. luckily, her father’s employer had recently transferred him from montreal to markham, near toronto and that city’s sick kids hospital.
there, she underwent the fontan procedure, open-heart surgery, which allows oxygenated-poor blood from the lower body to bypass the heart and go straight to the pulmonary artery and onto the lungs.
“that made me pretty close to normal,” she says. “if we hadn’t moved, i probably wouldn’t be here.”
during her mid-twenties, she underwent a series of cardioversions — quick electric shocks to reset her heart rhythm. she also had a cardiac ablation to block irregular electrical signals. that helped only temporarily—a few years later, she had another, which was more advanced. with her heart ticking along relatively normally, she was able to have a child. “but i knew that i wasn’t going to have a second one biologically because it was a risky pregnancy.” two years later, she and her husband adopted a daughter.